Ítem
Acceso Abierto

Intravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecture

Mostrar el registro sencillo de la publicación
dc.creatorArevalo J.F.spa
dc.creatorLiu T.Y.A.spa
dc.creatorWu L.spa
dc.creatorLasave A.F.spa
dc.creatorFarah M.spa
dc.creatorMaia M.spa
dc.creatorPenha F.M.spa
dc.creatorRodrigues E.B.spa
dc.creatorMorales-Canton V.spa
dc.creatorFromow-Guerra J.spa
dc.creatorGuerrero-Naranjo J.L.spa
dc.creatorDalma-Weiszhausz J.spa
dc.creatorVelez-Montoya R.spa
dc.creatorQuiroz-Mercado H.spa
dc.creatorRodriguez F.J.spa
dc.creatorGomez F.E.spa
dc.creatorBrieke A.C.spa
dc.creatorGoveto A.spa
dc.creatorBerrocal M.H.spa
dc.creatorCruz-Villegas V.spa
dc.creatorGraue-Wiechers F.spa
dc.creatorLozano-Rechy D.spa
dc.creatorFulda-Graue E.spa
dc.creatorRoca J.A.spa
dc.creatorHernández A.spa
dc.creatorSaravia M.J.spa
dc.creatorSchlaen A.spa
dc.creatorRojas J.spa
dc.creatorIngolotti M.spa
dc.creatorAvila M.spa
dc.creatorCarla L.spa
dc.creatorCardillo J.spa
dc.creatorJorge R.spa
dc.creatorCarpentier C.spa
dc.creatorVerdaguer J.spa
dc.creatorVerdaguer J.I.spa
dc.creatorSepúlveda G.spa
dc.creatorAlezzandrini A.spa
dc.creatorGarcia B.spa
dc.creatorZas M.spa
dc.creatorGallego-Pinazo R.spa
dc.creatorDiaz-Llopis M.spa
dc.creatorDolz-Marco R.spa
dc.creatorFigueroa M.spa
dc.creatorContreras I.spa
dc.creatorRuiz-Casas D.spa
dc.creatorPan-American Collaborative Retina Study Group (PACORES)spa
dc.creator.OrganizationalPan-American Collaborative Retina Study Group (PACORES)
dc.date.accessioned2020-05-25T23:59:38Z
dc.date.available2020-05-25T23:59:38Z
dc.date.created2018spa
dc.description.abstractThe advent of intravitreal anti-vascular endothelial growth factor (anti-VEGF) medications has revolutionized the treatment of diabetic eye diseases. Herein, we report the outcomes of clinical studies carried out by the Pan-American Collaborative Retina Study Group (PACORES), with a specific focus on the efficacy of intravitreal bevacizumab in the management of diabetic macular edema and proliferative diabetic retinopathy. We will also discuss the use of intravitreal bevaci-zumab as a preoperative, adjuvant therapy before vitrectomy for prolif-erative diabetic retinopathy. Copyright © 2017 by Asia Pacific Academy of Ophthalmology.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.22608/APO.2017466
dc.identifier.issn21620989
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/23077
dc.language.isoengspa
dc.publisherAsia-Pacific Academy of Ophthalmologyspa
dc.relation.citationEndPage39
dc.relation.citationIssueNo. 1
dc.relation.citationStartPage36
dc.relation.citationTitleAsia-Pacific Journal of Ophthalmology
dc.relation.citationVolumeVol. 7
dc.relation.ispartofAsia-Pacific Journal of Ophthalmology, ISSN:21620989, Vol.7, No.1 (2018); pp. 36-39spa
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85044056870&doi=10.22608%2fAPO.2017466&partnerID=40&md5=0cc533e1f1354ee7e15b351f2196ef83spa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordAngiogenesis inhibitorspa
dc.subject.keywordBevacizumabspa
dc.subject.keywordAdjuvant chemotherapyspa
dc.subject.keywordDiabetic retinopathyspa
dc.subject.keywordHumanspa
dc.subject.keywordIntravitreal drug administrationspa
dc.subject.keywordMacular edemaspa
dc.subject.keywordPreoperative carespa
dc.subject.keywordAngiogenesis inhibitorsspa
dc.subject.keywordBevacizumabspa
dc.subject.keywordChemotherapyeng
dc.subject.keywordDiabetic retinopathyspa
dc.subject.keywordHumansspa
dc.subject.keywordIntravitreal injectionsspa
dc.subject.keywordMacular edemaspa
dc.subject.keywordPreoperative carespa
dc.subject.keywordBevacizumabspa
dc.subject.keywordDiabetic macular edemaspa
dc.subject.keywordIntravitreal injectionsspa
dc.subject.keywordProliferative diabetic retinopathyspa
dc.subject.keywordTractional retinal detachmentspa
dc.titleIntravitreal bevacizumab in diabetic retinopathy. Recommendations from the Pan-American Collaborative Retina Study Group (PACORES): The 2016 knobloch lecturespa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Bloque original
Mostrando1 - 1 de 1
Miniatura
Nombre:
Intravitreal_Bevacizumab_in_Diabetic_Retinopathy_6.pdf
Tamaño:
414.09 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Colecciones
Artículos